Smartlab Europe

Human Lungs Created To Test Drugs By Australian Scientists

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Novartis China Investment Expands R&D and Manufacturing

Novartis is stepping up its presence in China with...

UK Backs Respiratory Transformation Partnership with £10m

The NHS has partnered with leading pharmaceutical companies to...

The Invisible Costs Undermining Pharma Profit Margins and the Digital Fixes Gaining Traction

Pharmaceutical companies spend extraordinary amounts optimising what they can...
- Advertisement -

University of Australia scientists, with collaborators from South Korea, China, and, of course, Australia, have gone on to develop a step-wise blueprint so as to create advanced human lung models in the lab, which, according to them, is going to accelerate the exploration and also the development of novel drugs and thereby reduce reliance on animal testing to gauge their efficacy.

Notably, lab-made lungs that are named organoids or mini organs are 3D structures that are grown from human primary cells that mirror actual organs in the body. They, as a matter of fact, serve as a testing ground when it comes to biomedical research.

Professor of nanomedicine at the Sydney Pharmacy School, Wojciech Chrzanowski, who happens to be the faculty of medicine and a member of the Charles Perkins Centre as well as a senior author, opines that this work is important since, because of it, they will be able to lessen the animal numbers in medical research, speed up the discovery of new drugs, and also accelerate innovative strategies when it comes to treating diseases.

It is well to note that Australia went on to ban cosmetic animal testing in 2020, and even the United States passed legislation last year ending the requirement that new drugs be tested on animals.

Significantly, these artificial lung models put Australia at the forefront in mini organ research, said Professor Wojciech Chrzanowski, who has been asking for the establishment of a national centre for medical research alternatives to animal methodology.

Latest stories

Related stories

Novartis China Investment Expands R&D and Manufacturing

Novartis is stepping up its presence in China with...

UK Backs Respiratory Transformation Partnership with £10m

The NHS has partnered with leading pharmaceutical companies to...

The Invisible Costs Undermining Pharma Profit Margins and the Digital Fixes Gaining Traction

Pharmaceutical companies spend extraordinary amounts optimising what they can...

SGD Pharma Advances Nasal Drug Delivery with Prince Deal

SGD Pharma has entered into a Franco-American OEM collaboration...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »